|Day Low/High||70.36 / 72.33|
|52 Wk Low/High||54.32 / 74.15|
Here's why October was a dream for investors.
ABBOTT PARK, Ill., Nov.
Markets had another volatile week as trade tensions crossed currents with a U.S. midterm election that was closer than many had predicted.
We think defense stocks, among other sectors, can rally.
Stephen 'Sarge' Guilfoyle gives you a rundown of what's in his portfolio as the new month gets rolling.
In light of recent market volatility, we want club members to know our view on every stock we own.
A lot of names now suddenly present as dividend plays that maybe we do not think of in that way.
NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT
It becomes difficult for me to tell you where to run in these markets...
This earnings season could be full of surprises. Jim Cramer has your game plan for next week.
Jim Cramer says there's still too much greed and complacency, and not enough fear and panic.
Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.
Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.
Jim Cramer takes a look at United Parcel Service, TJX Companies, Anheuser-Busch InBev, Fiat Chrysler, AbbVie, Nvidia, Excelixis, Bank of America, Endo Pharmaceutical and more.
Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.
Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.
Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.
Jim Cramer says investors should turn this Turkey-induced selloff into a buying opportunity.
This type of action is why we often say that an up-open cannot be trusted in a volatile market.
BP is on our list of high-quality stocks we are looking to pick up on a broader market pullback.
This fits with our strategy of looking for names that already reported strong quarters and are being overlooked due to broader market weakness.
- Advanced heart failure patients who will live with their device for the rest of their life now have access to a heart pump backed by the industry's strongest long-term data
We hope you found our conversation valuable.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.